China cosmetics regulations 2026 require beauty brands to plan compliance before finalizing a formula, label, claim, manufacturer, or launch schedule. The core framework remains the Cosmetics Supervision and Administration Regulation (CSAR), but 2026 also brings practical developments, including a cosmetics electronic-label pilot that began on February 1, 2026, and the continued implementation of stricter safety-assessment, ingredient, efficacy, and post-market obligations.
This guide explains the main requirements for global brands manufacturing cosmetics in China or placing imported cosmetics on the Chinese market. It is general business information, not legal advice. Product classification, formula, claims, sales channel, applicant structure, and local implementation can change the required pathway, so brands should confirm the current NMPA rules for each project.
China Cosmetics Regulations 2026: The Core Framework
China’s modern cosmetics system is built around CSAR, which took effect on January 1, 2021, and its supporting rules. The National Medical Products Administration (NMPA) oversees cosmetics registration and filing, new cosmetic ingredients, standards, inspection, and post-market supervision. Provincial and local medical products administrations also perform filing, inspection, and enforcement functions within their authority.
The system places primary responsibility for product quality, safety, and efficacy claims on the cosmetic registrant or filing entity. A contract manufacturer does not remove that responsibility. The registrant or filing entity must maintain an appropriate quality-management system, conduct or commission safety assessment and required testing, monitor adverse reactions, manage risks, and ensure that submitted information is authentic and scientifically supportable.
General Cosmetics Filing vs. Special Cosmetics Registration
The first regulatory decision is product classification. China uses different pre-market pathways for general and special cosmetics.
- General cosmetics are managed through filing before they are marketed or imported. Most routine skin care, makeup, fragrance, and cleansing products fall within this route when they do not make special-cosmetic claims.
- Special cosmetics require registration before production or import. The special category includes products for hair dyeing, hair perming, spot correcting or whitening, sun protection, preventing hair loss, and cosmetics claiming a new efficacy.
Classification must follow the product’s intended use and claims, not only its format. A cream, serum, or makeup product can move into a different regulatory route when its claims imply a regulated special efficacy. General cosmetics must not claim the efficacy of special cosmetics.
Overseas Brands Need a Domestic Responsible Person
An overseas cosmetic registrant or filing entity must designate an enterprise legal person in China as its domestic responsible person. This role is more than a mailing address. Under the registration and filing provisions, the domestic responsible person handles submissions in the name of the overseas company, assists with adverse-reaction monitoring and new-ingredient safety reporting, supports recalls, and cooperates with regulatory supervision.
Before appointing a partner, define access to technical data, formula confidentiality, submission authority, change control, complaint handling, adverse-event communication, recall execution, record retention, and termination procedures. A weak agreement can create operational problems even when the initial filing succeeds.
Safety Assessment Is a Pre-Market Requirement
A cosmetic safety assessment must be completed before registration or filing. NMPA’s 2024 measures allowed simplified safety-assessment reports during a transition period that ended before May 1, 2025. The same measures also introduced classified management: some qualifying general cosmetics may submit basic safety-assessment conclusions while retaining the supporting report for inspection. This does not remove the company’s duty to assess safety or lower the product-safety standard.
In practice, a defensible safety file may require the complete formula, ingredient specifications, impurity and risk-substance information, exposure assumptions, toxicological evidence, packaging compatibility information, stability and microbiological data, test reports, and assessor qualifications. The appropriate evidence depends on the product and ingredients. Formula changes, supplier changes, new safety information, or revised use conditions may trigger reassessment.
Ingredient Compliance and the 2025 IECIC Structure
Ingredient screening should happen during formulation, not after artwork is complete. Brands must confirm that each ingredient is permitted for its intended function, use area, concentration, and user group under China’s current standards and technical specifications.
In 2025, NMPA updated the management of the Inventory of Existing Cosmetic Ingredients in China (IECIC). The inventory is now managed through two sublists. List I contains the revised and refined existing inventory, while List II is used for new cosmetic ingredients that complete the required three-year safety-monitoring period without identified safety concerns. Brands should use the current NMPA query channel rather than relying on an old spreadsheet or an ingredient’s status in another country.
If an ingredient is considered new for cosmetic use in China, it may require registration or filing before use. Higher-risk new ingredients, including those functioning as preservatives, sunscreens, colorants, hair dyes, spot correctors, or whitening agents, follow the registration pathway. Other eligible new ingredients may be filed, but post-filing does not end the obligation: new ingredients are subject to a three-year safety-monitoring system.
Efficacy Claims Need Evidence
Marketing language must be aligned with the registered or filed product information. NMPA’s Standard for the Evaluation of Efficacy Claims of Cosmetics requires claims to have an appropriate evidence basis, and claim-summary information must be disclosed through the regulatory platform where required.
Evidence may include literature, laboratory testing, consumer-use evaluation, or human efficacy testing, depending on the claim and applicable rules. Spot-correcting and whitening, sunscreen, and anti-hair-loss claims receive particular regulatory attention. A statement used on packaging, an e-commerce product page, a livestream, or social media can create the same compliance risk as a statement printed on the container.
NMPA’s November 2025 reform Opinions describe future optimization, including more flexible method selection for many claims and data-sharing for certain similar products. These Opinions set a regulatory reform direction; brands should verify the detailed implementing requirements before changing an established testing plan.
Chinese Cosmetic Label Requirements
Cosmetics sold in China must comply with the Measures for the Administration of Cosmetics Labels and related standards. The Chinese label must be truthful, complete, clear, and consistent with the registration or filing information. Depending on the product, required content can include the Chinese product name, registrant or filing entity, domestic responsible person for imported products, manufacturer, product standard number, full ingredient list, net content, use method, necessary warnings, shelf-life information, and special-cosmetic registration number.
Translation is not a purely linguistic exercise. Product names, ingredient names, efficacy statements, warnings, and responsible-party details must be checked against Chinese regulatory terminology and the submission dossier. Physical packaging, online listings, advertising, and distributor materials should use consistent claims.
New for 2026: Cosmetics Electronic-Label Pilot
Starting February 1, 2026, NMPA launched a pilot program for cosmetic electronic labels in Beijing, Shanghai, Zhejiang, Shandong, Guangdong, and Chongqing. Participating enterprises may display required Chinese label information through an approved electronic-label system, subject to the pilot requirements.
The pilot is not a nationwide exemption from physical labels. The QR code must meet technical and display rules, required information must open directly without obstructive pop-ups, and the electronic content must match the registration or filing information. Certain information still needs to appear on the physical sales package, including the Chinese product name, registrant or filing entity, net content, shelf life, applicable warnings, and the children’s-cosmetics symbol when relevant. Brands should participate only through the applicable pilot process and should not replace standard labeling based on a general QR code.
Testing and Technical Documentation
Registration or filing dossiers may require product testing, formula and ingredient information, product standards, label samples, safety-assessment materials, manufacturing information, and claim evidence. Required testing must be performed according to the applicable NMPA rules and by an eligible testing institution where qualification is required.
Methods continue to change. For example, NMPA issued new and revised methods for azelaic acid and its salts, phenacetin, asbestos, and other substances, with specified methods applying to relevant registration, filing, and sampling tests from July 1, 2025. A brand should confirm the current method before commissioning a test; reusing an old report without checking the method and product scope can create a dossier gap.
Manufacturing, Quality Management, and Traceability
Cosmetics manufactured in China must be produced by an enterprise holding the appropriate cosmetics manufacturing license. The registrant or filing entity and the contract manufacturer must implement quality systems covering supplier selection, incoming-material control, formula and process review, manufacturing controls, equipment, testing, release, sample retention, records, and traceability.
When manufacturing is outsourced, the brand-side registrant or filing entity must supervise the manufacturing process and remains responsible for product quality and safety. A manufacturing agreement should therefore cover approved formulas and suppliers, specifications, deviations, change notification, batch release, complaints, adverse reactions, recalls, document access, and regulatory inspections.
Post-Market Duties Continue After Launch
Compliance does not end when a filing number or registration certificate is obtained. General cosmetics are subject to annual reporting requirements. Registrants, filing entities, domestic responsible persons, manufacturers, and sellers must maintain records, monitor adverse reactions, investigate safety signals, manage complaints, and take risk-control or recall action when necessary.
Online sales are also regulated. Product information displayed by e-commerce operators should be comprehensive, accurate, and consistent with the product label and regulatory information. Brands should control distributor content and marketplace listings rather than treating them as independent marketing materials.
A Practical 2026 Compliance Workflow
- Define whether the product will be manufactured for export only, sold in China, or imported into China.
- Classify the product as general or special based on intended use and claims.
- Confirm the registrant or filing entity and, for an overseas company, appoint a qualified domestic responsible person.
- Screen every ingredient against the current IECIC, restricted-use requirements, and new-ingredient rules.
- Freeze the formula, specifications, suppliers, packaging, claims, and target users before final testing.
- Develop the safety-assessment strategy and collect ingredient and product evidence.
- Select the required testing and efficacy-evaluation methods.
- Prepare Chinese labels and verify consistency across the dossier, physical packaging, and online sales pages.
- Submit the registration or filing dossier through the applicable route.
- Establish post-market reporting, adverse-reaction, complaint, change-control, and recall procedures before launch.
How Ya-Orange Supports Global Beauty Brands
Ya-Orange supports beauty brands with OEM/ODM formulation, licensed cosmetics manufacturing, ingredient and formula documentation, product specifications, label-information coordination, testing coordination, quality records, and technical information needed for a regulatory dossier. We work with customers to identify data needs early so that formula, packaging, claims, and production records remain consistent.
Ya-Orange does not replace the registrant, filing entity, domestic responsible person, testing institution, or legal adviser. Final classification, registration or filing, claim approval, and market compliance remain the responsibility of the applicable regulatory parties.
Explore our cosmetic OEM/ODM process, review our cosmetic R&D capabilities, browse private label cosmetic products, or contact Ya-Orange to discuss the technical documentation required for your project.
Official sources: NMPA: Cosmetics Supervision and Administration Regulation; Provisions for Registration and Filing of Cosmetics; Measures to Optimize Cosmetic Safety Assessment; 2025 IECIC Administration Announcement; and 2026 Electronic-Label Pilot Notice.